ADAGENE INC. - ADS EACH REPRESENTING 1.25 ORDINAR

Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021

13 4月 2021 06:45:00 条件 Nasdaq GlobeNewswire

Adagene Reports Full Year 2020 Financial Results and Provides Corporate Updates

31 3月 2021 06:45:00 条件 Nasdaq GlobeNewswire

Adagene Announces Clinical Advancement for ADG116

29 3月 2021 06:45:00 条件 Nasdaq GlobeNewswire

Adagene Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option

11 2月 2021 09:08:31 条件 Nasdaq GlobeNewswire

Adagene Inc. Announces Pricing of Initial Public Offering

09 2月 2021 08:00:13 条件 Nasdaq GlobeNewswire